failure to respond or late response
on 13 Apr 2021
Last Applicant/ Owned by
3075 Townsgate Road, Suite 140
Westlake
CA
91361
Serial Number
90005160 filed on 16th Jun 2020
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Biomanufacturing, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; manufacture of nano scale material for use in the manufacture of other goods; manufacturing of pharmaceutical preparations for use in gene therapy; manufacturing of ph Read More
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, for development of therapeutics and the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith
Pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in gene delivery technology; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer
Biomanufacturing, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; manufacture of nano scale material for use in the manufacture of other goods; manufacturing of pharmaceutical preparations for use in gene therapy; manufacturing of pharmaceutical preparations for use in gene delivery technology; manufacturing of pharmaceutical preparations for use in the treatment of gene therapy treatable diseases; manufacturing of pharmaceutical preparations for the treatment of disorders of the central nervous system; manufacturing of pharmaceutical preparations for the treatment of cancer; manufacture of pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer
Pharmaceutical research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development; scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical, scientific, pharmaceutical and development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and delivery development of biochemical assays; biomedical, scientific, pharmaceutical and development services in the fields of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders
Medical services, namely, genetic engineering and gene therapy services; medical services, namely, gene therapy design and delivery services in the field of genetic diseases and disorders; medical services, in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; and pre-filled syringes and vials containing pharmaceutical preparations for the treatment of the aforementioned diseases and disorders and complications associated therewith; providing patient support services relating to the treatment of medical disorders, namely, providing online information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to patients; providing patient support services relating to cancer and cancer treatment in the nature of an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information services, namely, providing medical consultancy and advisory services via a global computer network in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing information services relating to treatment of medical disorders, namely, providing information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel
No 90005160
No Service Mark
No 08216
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
13th Apr 2021 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
13th Apr 2021 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
26th Jan 2021 | ASSIGNED TO EXAMINER |
30th Sep 2020 | NON-FINAL ACTION E-MAILED |
30th Sep 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
30th Sep 2020 | NON-FINAL ACTION WRITTEN |
17th Sep 2020 | ASSIGNED TO EXAMINER |
14th Jul 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
19th Jun 2020 | NEW APPLICATION ENTERED IN TRAM |